Epidemiology and Prevention of Infection and Related Diseases

This pre-solicitation notice seeks epidemiology and prevention services to be performed in Costa Rica. The National Cancer Institute, in collaboration with Costa Rican institutions, conducts studies on cervical cancer, HPV infection, and other infectious diseases. The contractor will continue long-term follow up of over 35,000 participants in HPV vaccine clinical trials and evaluations, allowing assessment of vaccine effectiveness over time. Services include maintaining approvals, preparing and translating study materials, training staff, recruiting and following participants, coordinating with collaborators, and providing data management and specimen processing. New studies may also evaluate SARS-CoV-2 and other pathogens. The National Institutes of Health National Cancer Institute will issue solicitation number 75N91024R00005 for these services, with questions due by December 18, 2023.

There is no set-aside designation for this procurement. The main NAICS code is 541715 and PSC code is R425. The incumbent contractor providing these services is not named in the pre-solicitation notice. The value and period of performance for any resulting contract are not specified, though the long-term nature of existing studies suggests the work will continue for multiple years. Over 35,000 participants are currently enrolled across various clinical trials and evaluations.